334.07 0.00 (0.00%)
After hours: 5:57PM EST
|Bid||324.41 x 200|
|Ask||352.76 x 200|
|Day's Range||333.17 - 338.72|
|52 Week Range||231.90 - 355.88|
|Beta (3Y Monthly)||1.02|
|PE Ratio (TTM)||34.53|
|Earnings Date||Feb 5, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||2.00 (0.59%)|
|1y Target Est||385.84|
Carter Worth, Cornerstone Macro, on quality bear-market stocks to buy. With CNBC's Joe Kernen and the Fast Money traders, Pete Najarian, Steve Grasso, Brian Kelly and Tim Seymour.
Ana Gupte, Leerink Partners senior analyst and managing director of healthcare services, discusses the outlook for health care following the midterm elections creating a divided Congress.
LOUISVILLE, Ky.-- -- Fifth year of reporting value-based care reveals quality improvements and lower cost For the fifth year in a row, Humana Inc. unveiled findings that detail how physician practices in value-based care agreements are increasing preventive care, improving health outcomes and quality measures, and lowering overall health care costs for Humana Medicare Advantage members. This press ...
The Zacks Analyst Blog Highlights: Altria, American Express, U.S. Bancorp, T-Mobile and Humana
Two executives with Louisville-based Humana Inc. have filed notice they will sell millions in company stock. Humana Chief Medical Officer Roy Beveridge and Chief Human Resources officer Timothy Huval filed notices with the Securities and Exchange Commission, saying they plan to sell an estimated $3.4 million in Humana stock. The sales come at a time when Humana's share price has hit another all-time high.
The Humana Foundation, philanthropic arm of Humana Inc. (HUM) for the past 37 years, is investing nearly $7 million in 2018 in organizations that are focused on helping people who struggle with issues ranging from food security to social connection to financial independence. The contributions will go to nine organizations in seven Humana ‘Bold Goal’ communities across the U.S. These are communities where Humana is working to achieve a goal of helping people improve their health 20 percent by 2020.
Given this chart and analysis, my trading strategy is to buy Aetna shares on weakness to annual value level of $161.49 and reduce holdings on strength to my quarterly risky level at $218.10. Given this chart and analysis, traders should buy Anthem shares on weakness to my annual value level of $194.00 and reduce holdings on strength to my quarterly risky level at $300.91. Given this chart and analysis, I suggest buying Humana shares on weakness to my annual value level of $253.11 and reducing holdings on strength to my quarterly risky level at $353.33, which was tested after the election on Nov. 7.
For-profit hospice providers now outnumber community-based nonprofits that for the better part of the last century prided themselves on caring for their own. Many today are keeping a watchful eye on the ever-changing health care landscape and what the future might bring.
Humana earnings, the Democratic House takeover and Medicaid expansions in 3 states sent health insurers soaring Wednesday. Humana and several peers hit buy points.
Humana (HUM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The stock market closed with sharp gains Wednesday after the midterm elections brought no major surprises and removed a cloud of uncertainty over Wall Street.
In stock news today, Twilio and Tableau Software gapped up on strong earnings. Health insurers also outperformed, helped by midterm election results.
The company will next report results on Feb. 1 before the bell. Analysts are looking for earnings of $1.05 per share on revenues of $10.99 billion. When the company last reported on Oct. 25 earnings of $1.19 per share beat estimates by five cents on a 4.5% rise in revenues.
Investing.com - Humana (NYSE:HUM) reported third quarter earnings that beat analyst's expectations on Wednesday and revenue that fell short of forecasts.
Here's what Humana Inc. CEO Bruce Broussard and CFO Brian Kane told investors in the company's third-quarter earnings call.